INTERNATIONAL JOURNAL OF SCIENTIFIC DEVELOPMENT AND RESEARCH International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2455-2631 | Impact factor: 8.15 | ESTD Year: 2016
open access , Peer-reviewed, and Refereed Journals, Impact factor 8.15
Caner remains a serious threat to global public health, responsible for an estimated 1.5 million mortalities in 2021. While there are available therapeutics for this infection, slow-acting drugs, poor patient compliance, drug toxicity, and drug resistance require the discovery of novel anticancer drugs. Discovering new and more potent drugs that target novel cancer cell line, enzymes is an attractive strategy towards controlling the global cancer epidemic. There has been a need to develop drugs that are less toxic and do not provide resistance in the long run. Thus, this need-based development of anticancer drugs through the use of different molecule has gained its pace since last two decades and there has been a gush among the researchers to apply various approaches in designing anticancer molecules. More specifically, research is being targeted on the utilization of molecular modeling techniques for developing new anticancer agents specifically targeting various cancer cell lines, specific enzymes and tissues. Some of the important and conclusive findings using this approach have been presented in this report.
"Review on molecular modelling studies of anti-cancer drugs", International Journal of Science & Engineering Development Research (www.ijsdr.org), ISSN:2455-2631, Vol.8, Issue 3, page no.1116 - 1124, March-2023, Available :http://www.ijsdr.org/papers/IJSDR2303185.pdf
Downloads:
000337348
Publication Details:
Published Paper ID: IJSDR2303185
Registration ID:204712
Published In: Volume 8 Issue 3, March-2023
DOI (Digital Object Identifier):
Page No: 1116 - 1124
Publisher: IJSDR | www.ijsdr.org
ISSN Number: 2455-2631
Facebook Twitter Instagram LinkedIn